UCBJY:OTCMKTS
UCB Unsponsored Belgium ADR
114,46 $
arrow_downward
-0,87%(-1,01) 1D
16 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UCBJY...
Open
114,95 $
High
115,28 $
Low
114,23 $
Mkt. cap
39,39 մլրդ
Avg. vol.
53,31 հզր
Volume
70,57 հզր
52-wk high
168,76 $
52-wk low
110,55 $
Beta
0,57
Shares outstanding
389,01 մլն
No. of employees
9 հզր
Open
114,95 $
High
115,28 $
Low
114,23 $
Mkt. cap
39,39 մլրդ
Avg. vol.
53,31 հզր
Volume
70,57 հզր
52-wk high
168,76 $
52-wk low
110,55 $
Beta
0,57
Shares outstanding
389,01 մլն
No. of employees
9 հզր
News stories
From web sources and news partners
Business Wire
·
29 րոպե առաջ
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR to Hold Listing Ceremony and First Investor Day at the Nasdaq Tower on Oct. 26; Three New Robotics Product Offerings Launched
TradingView
·
50 րոպե առաջ
News by CNBC TV18 on TradingView, 2026-10-18 — cnbctv:f99f7968e094b:0
Simply Wall Street
·
47 րոպե առաջ
KLA (KLAC) Stock Is Caught In A Historic Chip Equipment Losing Streak
Bloomberg.com
·
1 ժամ առաջ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
About UCB Unsponsored Belgium ADR